+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Spironolactone"

From
From
From
From
Finerenone - Product Thumbnail Image

Finerenone

  • Report
  • February 2019
  • 19 Pages
  • Global
From
Drug Analysis: Finerenone - Product Thumbnail Image

Drug Analysis: Finerenone

  • Drug Pipelines
  • February 2018
  • 19 Pages
  • Global
From
Global and Chinese Spironolactone Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Spironolactone Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 135 Pages
  • China, Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Spironolactone is a type of cardiovascular drug used to treat high blood pressure, heart failure, and other conditions. It is a potassium-sparing diuretic, meaning it helps the body get rid of excess water while preserving potassium. It is also used to treat primary hyperaldosteronism, a condition in which the body produces too much of the hormone aldosterone. Spironolactone is available in both generic and brand-name forms. The spironolactone market is highly competitive, with many companies offering generic and brand-name versions of the drug. Companies such as Pfizer, Merck, and Novartis are some of the major players in the market. Other companies such as Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals also offer generic versions of the drug. The spironolactone market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the growing demand for generic drugs. Companies are investing in research and development to develop new formulations of the drug and to improve its efficacy. Show Less Read more